{"name":"AiViva BioPharma, Inc.","slug":"aiviva-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AIV007","genericName":"AIV007","slug":"aiv007","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AIV007","genericName":"AIV007","slug":"aiv007","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOZkpoOHZJTjRkbXVuWFhqZXVEMWM0b2pzaHQ3dTFZQWFQR3YxUVVzLU8ya2JEbEhKVjEtenMwb20xSDNfRE1tMTd0Qlg0bGROVmdyVURTQjM0STg3Q195aC1zVjJSbnFlR3FOd29PTm8ybGNGWGpkTFd0WERhek1scDEtc1JmUDdkVWxGendmd1Nnbklv?oc=5","date":"2026-03-12","type":"regulatory","source":"openPR.com","summary":"Diabetic Macular Edema Treatment Pipeline Shows Strong - openPR.com","headline":"Diabetic Macular Edema Treatment Pipeline Shows Strong","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPTmhxaDdQVGplazVBRVYzV2tlVHVTUGVEdlN2WmtLd1dCclBJREVfbU5Sby1qRVQyZGVnMFAzRWJha3p4RGlXRjRYYWx0NHU2S2k5aV9CWjVoanRRcWV2QzZFcHFTX3hJWEI0b3VSSDBSQlQ2VU9FazdzbDBVeEZyLXUxYzVSdFk1RnFsVXM3VUE4RmJaV2FXME1XczBuaS1PRERlMzlicWF1MWp6ZEllQ3NLd0JZMHB4MXN2aGtaVm5iMk5WRXVDOTJZeVRTVElNNUpBLWd2T0NVb2Z5M1dRMmF5aXZWTkFZNTU1NVV3dVdKRUpOS3FSMG1pS3B4UkZRR0FERUJQbndLeno3WTlJTmtEWC1mNVdsXzNCQ25aUzFlUU5lU01jV2F3VVVNYjVMcnh3VDJpUzRrclQ5?oc=5","date":"2025-12-04","type":"regulatory","source":"PR Newswire","summary":"Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approvals and Expanding Patient Pool | DelveInsight - PR Newswire","headline":"Basal Cell Carcinoma Market Poised for Steady Growth Throughout Forecast Period (2025-2034) Driven by Novel Drug Approva","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPekdqd0ZLQ3J3NXdXcHQ0NnFTR2ViQ0pyZEZaakVleWMtTVBhb0RuM1VCR2thT0pzb2xDZS1iQXpIWjg4S0tZVThMSmFCdndERG81VU1VMDVxZjMycmlSV1ZTTkV5bWhyY2JtZ2htSV9uNWpiX040SkFpWnFKN1RmWUtmT29qUFhJ?oc=5","date":"2025-09-10","type":"trial","source":"Yahoo Finance","summary":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Yahoo Finance","headline":"Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Ent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxONlluVjU2bnJRcElhYXNZQVR2ZFBBckZ6MHZvampycFE3dGhHdVpIb0dhNlkzRXVUQXFEdHl6VnR5Z3d6OXYtYVNsSkVZN0xFUVU4MTRrYTVwdDRXSkpWaGQtY1Fab1JRSlBzaXFmTVlLVDVoX3lhVTBLTkNJbGt5dHVRRlpSLU05Ni1jNlV6YWxwdEdIM05WcktCbHkzSTdtMXBOeENFS092VUUteDFEUURNOWJGeF9YZGFCaFFYdzBmdlIwbEN1MEJLUVB2dk1tU01QY0R4bllpbUFic1JONUYwRU5nclRMZUtPTVhuM1h1cHJlMGkzdFViblBNc0l5M1dNd1d0X0lHX182TjFCSTFsWlQ?oc=5","date":"2025-07-14","type":"trial","source":"businesswire.com","summary":"Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at ENDO 2025 - businesswire.com","headline":"Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxQVVdnSjJRc0VMZE9CbndrRFRsY3l5UzlqcG94YndoSlh1eUY1Z3Jhb05PLWU4ZU8zV3NpRnZ3eWJob3NncDR3blJlLWt4UWoxbWFBNHU5UVJkR0xxYmJLQktkWnJlNS1UU1NMRTV4NlUwME5qUDFNOG5GT2trQ1NTZkdkVU00Wi1YZFRvbUpwYk5aV3ozU1h0TzlXU0MyS09RcWg1VklTQk1ILVhncUlHNVdxSW9hVVRKazc4cG1DTkV5WXRSaHlqc0lKODZVMXpINTFSalNjaVlIMUxfdVZkV2pCSlU1d1M3RW03dzdCaw?oc=5","date":"2025-01-24","type":"pipeline","source":"BioSpace","summary":"Basal Cell Carcinoma Market Size to Reach USD 10.0 Billion by 2035, Impelled by Increased Awareness and Early Diagnosis - BioSpace","headline":"Basal Cell Carcinoma Market Size to Reach USD 10.0 Billion by 2035, Impelled by Increased Awareness and Early Diagnosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOX1hfWGltd2hmY29qcUo5YS16bTZpUWZoc3pjZWpTbGp0VTYtVTlyS1pFRk1HeEdkNm5WT202SldNYWhNSFdOX24taVBRTVhhQlNTQXMxZ0tpVHhlYkZyalVqTWVxc2lsMndHWTE1WGZOY3NtOWp4Skdyc25YWndHREVQejVBejJRcVJFcEQyREpISzVJaWRKWnVzODBjTTZPbV9CRjVZejhjWVJaZG50ME83UHFnOUV3V1NCaEpKYnB1THZEb3dF?oc=5","date":"2024-08-26","type":"trial","source":"BioPharma APAC","summary":"AiViva Biopharma Completes Enrollment in Phase 1 Trial of AIV007 for Wet AMD and DME - BioPharma APAC","headline":"AiViva Biopharma Completes Enrollment in Phase 1 Trial of AIV007 for Wet AMD and DME","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxOTzd0VHZtSWZSWldNOTU5eGNfM0JDczRScHVuZElzUFBVakpHcUdKaUV2MkZOQmhFMVgyQjNRd3d4cFdTUDFEQl9ZLXo2ZmpwN1pJSS0wcFJqRHpZVWR5N281QlZFWndraU1uSVVpWjNqUG9RVnBJamVxN1NVREhNM0MzYkdlM0RCeEp3TzdsUE9mdy1XZ1U3RmxIeVNMSExQUjhWOUdTX3lkRm1KN0NqN09PVjhWZ3FuSWFwbTdnWjhGeHlPTXIzczUxTnJ2V2x5RnRjZmZzcFJfa3FGcFRCOHRkQUZiR1V1OHBYSVJ3MzNVb3lYSWhPVUNlUE1yWmpRMmJrZ0NlTF9sazdDSmpOWlhFTzFjMnl6SjdpcjBzbVpDdDZyeE5DZUVXaS1tQnZncmsyWFNMVDRJRjctclBFaU9qa1duNFFDSkxpQTY4Z28?oc=5","date":"2024-01-15","type":"pipeline","source":"PR Newswire","summary":"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene - PR Newswire","headline":"Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE9ISHU1VHpxU1ZSWi13dHpyRllFbEhjanF1N2d3TUYtcGZmVGg4QUJvc0FKcXJOYlBYYmE1RldpYVo3V1J0alViZ0d2UjBIMnZtejl0NGt2Z1pGSWR6NVJvbTdORWF0TFpWenNZaHFHeTFkaHlucDBJcmpR?oc=5","date":"2023-05-23","type":"trial","source":"Clinical Trials Arena","summary":"AiViva begins Phase I trial of therapy for macular disease - Clinical Trials Arena","headline":"AiViva begins Phase I trial of therapy for macular disease","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}